drugset
drugset / Trial / NCT02178059

Relative Bioavailability Study to Compare Inhalation of Terbutaline Sulphate 1,5mg Via Turbuhaler M3 With Turbuhaler M2

NCT02178059 ↗

Phase 1 Completed 34 enrolled AstraZeneca
RandomizedCrossoverOpen-labelBasic science

Summary

Relative bioavailability study to compare inhalation of Terbutaline Sulphate 1,5mg via current version of Turbuhaler with inhalation via a new version

Timeline

Start
2014-08
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Terbutaline Small molecule 0.4 mg Other
Subject Terbutaline Small molecule 0.5 mg Other

Indications

No indication recorded.